Exploiting MYC Oncogenic Stress for Therapeutic Benefit in Lymphoma All Restricted

Kanangat, Smriti (Summer 2026)

Permanent URL: https://etd.library.emory.edu/concern/etds/w66345177?locale=en

Published

Abstract

This abstract is under embargo until 20 August 2028

Table of Contents

This table of contents is under embargo until 20 August 2028

About this Dissertation

Rights statement

Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.

School	Laney Graduate School
Department	Biological and Biomedical Sciences
Subfield / Discipline	Cancer Biology
Degree	Ph.D.
Submission	Dissertation
Language	English
Research Field	Biology, Cell Biology, Genetics Biology, Molecular
Keyword	BCL2 MYC Genomics Oncogene Precision medicine Transcription Lymphoma CRISPR Screen Targeted therapy Venetoclax DLBCL
Committee Chair / Thesis Advisor	Lawrence Boise, Emory University Louis Staudt, National Institutes of Health
Committee Members	David Frank, Emory University Andrew Hong, Emory University David Levens, National Institutes of Health

Last modified

Preview image embargoed

Primary PDF

Thumbnail	Title	Date Uploaded	Actions
	File download under embargo until 20 August 2028	2026-08-15 02:58:19 -0400	File download under embargo until 20 August 2028

Supplemental Files